Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 17.2
(6.57%)
CNY 17.2
(6.57%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 32.61 Million CNY | -34.4% |
| 2022 | 49.71 Million CNY | -8.32% |
| 2021 | 54.23 Million CNY | 67.65% |
| 2020 | 32.34 Million CNY | -74.61% |
| 2019 | 127.39 Million CNY | 622.65% |
| 2018 | 17.62 Million CNY | 7431.48% |
| 2017 | 234.06 Thousand CNY | -97.64% |
| 2016 | 9.9 Million CNY | 1403.25% |
| 2015 | 658.57 Thousand CNY | 2.14% |
| 2014 | 644.8 Thousand CNY | 58.75% |
| 2013 | 406.16 Thousand CNY | -65.33% |
| 2012 | 1.17 Million CNY | -4.25% |
| 2011 | 1.22 Million CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 168.11 Million CNY | -2.04% |
| 2024 Q1 | 27.11 Million CNY | -16.86% |
| 2024 Q2 | 171.61 Million CNY | 532.93% |
| 2023 Q2 | 46.6 Million CNY | -3.25% |
| 2023 Q4 | 32.61 Million CNY | -27.78% |
| 2023 Q1 | 48.17 Million CNY | -3.11% |
| 2023 FY | 32.61 Million CNY | -34.4% |
| 2023 Q3 | 45.15 Million CNY | -3.1% |
| 2022 Q4 | 49.71 Million CNY | -2.18% |
| 2022 Q3 | 50.82 Million CNY | -3.05% |
| 2022 Q1 | 52.17 Million CNY | -3.8% |
| 2022 Q2 | 52.42 Million CNY | 0.49% |
| 2022 FY | 49.71 Million CNY | -8.32% |
| 2021 Q2 | 41.76 Million CNY | 24.52% |
| 2021 FY | 54.23 Million CNY | 67.65% |
| 2021 Q1 | 33.53 Million CNY | 3.68% |
| 2021 Q3 | 35.92 Million CNY | -13.97% |
| 2021 Q4 | 54.23 Million CNY | 50.95% |
| 2020 FY | 32.34 Million CNY | -74.61% |
| 2020 Q3 | 118.61 Million CNY | -1.0% |
| 2020 Q2 | 119.8 Million CNY | -6.76% |
| 2020 Q1 | 128.48 Million CNY | 0.86% |
| 2020 Q4 | 32.34 Million CNY | -72.73% |
| 2019 Q2 | 144.42 Million CNY | 217.18% |
| 2019 Q4 | 127.39 Million CNY | -11.1% |
| 2019 FY | 127.39 Million CNY | 622.65% |
| 2019 Q1 | 45.53 Million CNY | 158.29% |
| 2019 Q3 | 143.29 Million CNY | -0.78% |
| 2018 Q4 | 17.62 Million CNY | -3.11% |
| 2018 FY | 17.62 Million CNY | 7431.48% |
| 2018 Q3 | 18.19 Million CNY | 7826.3% |
| 2018 Q1 | 234.06 Thousand CNY | 0.0% |
| 2018 Q2 | 229.54 Thousand CNY | -1.93% |
| 2017 Q3 | - CNY | -100.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 1.00 CNY | 0.0% |
| 2017 FY | 234.06 Thousand CNY | -97.64% |
| 2017 Q4 | 234.06 Thousand CNY | 0.0% |
| 2016 Q3 | 9.9 Million CNY | -85.86% |
| 2016 Q2 | 70 Million CNY | 0.0% |
| 2016 Q4 | 9.9 Million CNY | 0.0% |
| 2016 FY | 9.9 Million CNY | 1403.25% |
| 2016 Q1 | 70 Million CNY | 10529.03% |
| 2015 Q1 | 644.8 Thousand CNY | 0.0% |
| 2015 FY | 658.57 Thousand CNY | 2.14% |
| 2015 Q2 | 668.8 Thousand CNY | 3.72% |
| 2015 Q3 | 668.8 Thousand CNY | 0.0% |
| 2015 Q4 | 658.57 Thousand CNY | -1.53% |
| 2014 Q2 | 404.95 Thousand CNY | -0.3% |
| 2014 FY | 644.8 Thousand CNY | 58.75% |
| 2014 Q4 | 644.8 Thousand CNY | -60.77% |
| 2014 Q3 | 1.64 Million CNY | 305.86% |
| 2014 Q1 | 406.16 Thousand CNY | 0.0% |
| 2013 Q3 | 339.3 Thousand CNY | -53.48% |
| 2013 Q1 | 748.66 Thousand CNY | -36.1% |
| 2013 FY | 406.16 Thousand CNY | -65.33% |
| 2013 Q4 | 406.16 Thousand CNY | 19.7% |
| 2013 Q2 | 729.37 Thousand CNY | -2.58% |
| 2012 Q2 | 1.22 Million CNY | 0.0% |
| 2012 FY | 1.17 Million CNY | -4.25% |
| 2012 Q1 | 1.22 Million CNY | 0.0% |
| 2012 Q4 | 1.17 Million CNY | -4.25% |
| 2012 Q3 | 1.22 Million CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q3 | 1.29 Million CNY | 0.0% |
| 2011 FY | 1.22 Million CNY | 0.0% |
| 2011 Q4 | 1.22 Million CNY | -5.84% |
| 2011 Q1 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 671.68 Million CNY | 95.144% |
| Zhejiang Zhenyuan Share Co., Ltd. | 54.96 Million CNY | 40.659% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 94.96 Million CNY | 65.657% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 419.53 Million CNY | 92.226% |
| Yifan Pharmaceutical Co., Ltd. | 812.04 Million CNY | 95.984% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | - CNY | -Infinity% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.64 Billion CNY | 98.769% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 126.5 Million CNY | 74.218% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 21.25 Million CNY | -53.436% |